Low-dose methotrexate as rescue therapy in patients with hidradenitis suppurativa and pyoderma gangrenosum developing human antichimeric antibodies to infliximab: A retrospective chart review.
| Publicado en: | Journal of the American Academy of Dermatology Vol. 82; no. 2; pp. 507 - 511 |
|---|---|
| Autores principales: | , |
| Formato: | Journal Article |
| Publicado: |
Elsevier B.V.
Feb2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=141136318&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 141136318 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01909622 1ZF jtl: Journal of the American Academy of Dermatology issn: 01909622 maglogo: N pubinfo: dt: Feb2020 vid: 82 iid: 2 pid: 467 pub: Elsevier B.V. place: New York, New York artinfo: ui: 141136318 141136318 NLM31541746 10.1016/j.jaad.2019.09.012 NLM31541746 141136318 ppf: 507 ppct: 4 formats: tig: atl: Low-dose methotrexate as rescue therapy in patients with hidradenitis suppurativa and pyoderma gangrenosum developing human antichimeric antibodies to infliximab: A retrospective chart review. aug: au: Wang, Leo L. Micheletti, Robert G. affil: Perelman School of Medicine, University of Pennsylvania, Philadelphia sug: subj: Methotrexate Administration and Dosage Pyoderma Gangrenosum Drug Therapy Methotrexate Pharmacodynamics Hidradenitis Suppurativa Drug Therapy Antibody Formation Drug Effects Adult Male Aged Middle Age Retrospective Design Female Adult: 19-44 years Aged: 65+ years Middle Aged: 45-64 years Male Female pubtype: Academic Journal doctype: Journal Article ougenre: Unknown ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|